These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19876783)

  • 1. PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies.
    Harris SJ; Foster JG; Ward SG
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1151-62. PubMed ID: 19876783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
    Rommel C; Camps M; Ji H
    Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taming the PI3K team to hold inflammation and cancer at bay.
    Hirsch E; Ciraolo E; Ghigo A; Costa C
    Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs.
    Hilden TJ; Nurmi SM; Fagerholm SC; Gahmberg CG
    Ann Med; 2006; 38(7):503-11. PubMed ID: 17101541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Barberis L; Hirsch E
    Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
    Mackay CR
    Nat Immunol; 2008 Sep; 9(9):988-98. PubMed ID: 18711436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease.
    Marwick JA; Chung KF; Adcock IM
    Ther Adv Respir Dis; 2010 Feb; 4(1):19-34. PubMed ID: 20051446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal signaling molecules as potential targets for anti-inflammatory therapy.
    Löwenberg M
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):560-4. PubMed ID: 17786854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible anti-inflammatory role of COX-2-derived prostaglandins: implications for inflammation research.
    Kapoor M; Shaw O; Appleton I
    Curr Opin Investig Drugs; 2005 May; 6(5):461-6. PubMed ID: 15912958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
    Baugh JA; Bucala R
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.
    Dufton N; Perretti M
    Pharmacol Ther; 2010 Aug; 127(2):175-88. PubMed ID: 20546777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation.
    Hallett JM; Leitch AE; Riley NA; Duffin R; Haslett C; Rossi AG
    Trends Pharmacol Sci; 2008 May; 29(5):250-7. PubMed ID: 18407359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies.
    Geng JG
    Cell Res; 2001 Jun; 11(2):85-8. PubMed ID: 11453550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.
    Hawkins PT; Stephens LR
    Science; 2007 Oct; 318(5847):64-6. PubMed ID: 17916723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.